Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature.
Case Rep Endocrinol
; 2018: 4606491, 2018.
Article
en En
| MEDLINE
| ID: mdl-29854487
ABSTRACT
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Case Rep Endocrinol
Año:
2018
Tipo del documento:
Article
País de afiliación:
Estados Unidos